Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model
Animal Models and Experimental Medicine · 2026-07 · 9 (7) · 1292-1301
DOI: 10.1002/ame2.70233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 30.05.2026. Verfasst von Yangyun Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Mudanjiang Medical University, Heilongjiang, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Complement C3, Feces, Fibronectins. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Ulcerative colitis (UC) is a typical inflammatory bowel disease requiring long‐term management. Although fecal calprotectin (FC) is widely employed for assessing disease activity, it is still considered insufficient as a standalone tool. New biomarkers are needed to better predict risk and comprehensively reflect biological pathways. This study aimed to identify potential fecal biomarkers to monitor disease activity in UC.
Methods
C57BL/6J mice were exposed to dextran sulfate sodium (DSS) treatment for 7 days. Feces were collected and subjected to proteomic analysis and enzyme‐linked immunosorbent assay (ELISA). Mouse colon tissues were subjected to histopathological and immunofluorescence analyses. The correlations between the selected fecal proteins and disease severity were evaluated and compared with FC.
Results
Proteomic analysis revealed increases in fecal complement component 3 (C3) and fibronectin (FN) in the DSS group. Next, we measured fecal C3 and FN levels in mice using ELISA. Significant elevation in C3 and FN levels was observed as early as day 1 after DSS treatment, preceding the increase in FC. Both fecal C3 and FN demonstrated significant correlations with disease activity, with C3 exhibiting a stronger correlation than FC. Using immunofluorescence, we observed distinct C3 and FN expressions in both the colonic tissues and the intestinal lumen.
Conclusion
These findings demonstrate that fecal C3 and FN are promising candidate biomarkers for monitoring UC disease activity, and their utility requires further validation in other colitis models and human cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Mudanjiang Medical University, Heilongjiang, China.
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
ORCID-Profile: Yong Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, Y., Yan, Z., Ye, J., Yang, R., Song, Y., Yue, H., & Zhao, Y. (2026). Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model. Animal Models and Experimental Medicine, 9(7), 1292-1301. https://doi.org/10.1002/ame2.70233
Vancouver
Guo Y, Yan Z, Ye J, Yang R, Song Y, Yue H, et al. Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model. Animal Models and Experimental Medicine. 2026;9(7):1292-1301. doi:10.1002/ame2.70233
BibTeX
@article{Guo2026,
author = {Guo, Yangyun and Yan, Ziheng and Ye, Jingyu and Yang, Ruifu and Song, Yajun and Yue, Hui and Zhao, Yong},
title = {Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {7},
pages = {1292--1301},
doi = {10.1002/ame2.70233}
}
EUVIMED